Press Releases Percheron Therapeutics Limited Börse Stuttgart

Equities

AWY0

AU0000317281

Market Closed - Börse Stuttgart Other stock markets 07:05:11 28/06/2024 BST			5-day change	1st Jan Change
0.0482 ^EUR	-0.62%		-6.23%	+40.12%

06-17	Percheron Therapeutics Appoints CFO	MT
06-03	Percheron Therapeutics Names Chief Medical Advisor	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets	23/08/22	GL
Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets	22/08/22	GL
Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets	22/08/22	AQ
New Muscle Disease Indication for ATL1102 – Limb Girdle Muscular Dystrophy R2	22/06/22	GL
New Muscle Disease Indication for ATL1102 – Limb Girdle Muscular Dystrophy R2	22/06/22	AQ
Antisense Therapeutics : Prospectus	12/04/22	PU
Antisense Therapeutics to present poster at world’s largest NMD conference	09/03/22	GL
Antisense Therapeutics to present poster at world’s largest NMD conference	09/03/22	GL
Antisense Therapeutics : Application for quotation of securities - ANP	27/01/22	PU
Antisense Therapeutics : Quarterly Report and Appendix 4C	26/01/22	PU
Antisense Therapeutics : Application for quotation of securities - ANP	24/12/21	PU
Antisense Therapeutics : Application for quotation of securities - ANP	21/12/21	PU
Antisense Therapeutics : Annual General Meeting Presentation	14/12/21	PU
Antisense Therapeutics : Update - Proposed issue of securities - ANP	23/11/21	PU
Antisense Therapeutics : Morgans rates ANP as Add	02/07/21	AQ
Antisense Therapeutics : Announces a Poster Presentation on the Muscular Dystrophy Association Virtual Conference 2020 website	11/06/20	BU
Antisense Therapeutics : ATL1102 Final Phase II DMD Results Meet Primary Endpoint and Exceed Expectations on Secondary Endpoints	21/05/20	BU
Antisense Therapeutics : Announces Appointment of US-based Consultant Medical Director	27/02/20	BU
Antisense Therapeutics : Appointment of Non-Executive Director (G Pace)	09/11/15	PU
Antisense Therapeutics : ATL1103: Data Presentation at the Society for Endocrinology BES 2015 Conference	04/11/15	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Percheron Therapeutics Limited Börse Stuttgart

Equities

AWY0

AU0000317281

Press Releases

Filters